A Study of TAK-019 in Healthy Japanese Adults (COVID-19)

Clinical trial NCT04712110 · COMPLETED

Trial details

NCT number: NCT04712110
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

Start date: 2021-02-12
Primary completion: 2022-03-28
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.